Search Results 731-740 of 17104 for Balanced Macronutrient Ratios

  1. Laboratories - Mayo Clinic Research

    Early Life Immune Responses: Kathryn A. Knoop · Early-Onset Parkinson's Disease and Synucleinopathies: Rodolfo Savica · Elbow: Shawn W. O'Driscoll · Epigenetic ...

  2. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

    Ixazomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving cyclophosphamide together with ixazomib and ...

  3. Short-Wave Near Infrared (SWIR) Imaging System For Characterizing Lymphatic Anatomy - Mayo Clinic

    Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. Medical records research — uses historical ...

  4. Joel Streed | Mayo Clinic News Network - Page 83 of 170

    Common side effects of cancer treatment can include nausea, vomiting, fatigue and weight loss. These side effects make getting proper nutrition a challenge. To ...

  5. Evaluation of Laboratory Methods for Detecting Auto Antibodies to Complement Proteins - Mayo Clinic

    The goal of this study is to validate testing to be performed in the clinical immunology lab and have a source of positive patient sera. These tests include:.

  6. Publications - Mayo Clinic

    Coderre R, Martinez KA, Castrichini M, Bos JM, Giudicessi JR, Ackerman MJ. Return-to-Play for Athletes With Desmosomal Arrhythmogenic Cardiomyopathy: A ...

  7. Patient education - Mayo Clinic

    A Barbara Woodward Lips Patient Education Resource Center visitor reviews materials. Available Classes. Healthy Bones To Last a Lifetime. After attending ...

  8. A Study of AFP464 for Treating Patients with Solid Tumors that are Metastatic or Resistant to Treatment, and Cannot Be Removed By Surgery - Mayo Clinic

    Drugs used in chemotherapy, such as AFP464, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from ...

  9. An Extension Study To Assess The Safety Of The Use Of Cannabidiol In Children And Young Adults With Dravet Or Lennox-Gastaut Syndromes - Mayo Clinic

    The purpose of this extension study is to investigate the safety of using cannabidiol in children and young adults with Dravet or Lennox-Gastaut syndromes that ...

  10. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Participants will be randomized in a 2:1 ratio to Arm A (Atezolizumab + Nab-Paclitaxel + Carboplatin) or Arm B (Nab-Paclitaxel + Carboplatin). Participation ...